Compare AWK & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AWK | BNTX |
|---|---|---|
| Founded | 1886 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Water Supply | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.3B | 24.8B |
| IPO Year | 2008 | 2019 |
| Metric | AWK | BNTX |
|---|---|---|
| Price | $131.55 | $94.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $143.30 | $137.40 |
| AVG Volume (30 Days) | ★ 2.3M | 1.3M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | ★ 13.02 | N/A |
| EPS | ★ 5.69 | N/A |
| Revenue | ★ $5,070,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $9.16 | $2.36 |
| Revenue Next Year | $6.81 | N/A |
| P/E Ratio | $23.12 | ★ N/A |
| Revenue Growth | ★ 12.29 | 3.70 |
| 52 Week Low | $118.74 | $81.20 |
| 52 Week High | $155.50 | $129.27 |
| Indicator | AWK | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 38.15 |
| Support Level | $127.51 | $94.52 |
| Resistance Level | $132.20 | $97.35 |
| Average True Range (ATR) | 2.51 | 2.72 |
| MACD | 0.32 | -0.24 |
| Stochastic Oscillator | 68.86 | 8.21 |
American Water Works is the largest investor-owned US water and wastewater utility, serving nearly 4 million customers in 14 states. It provides water and wastewater services to residential, commercial, and industrial customers and operates predominantly in regulated markets. The company's nonregulated business is water services for military bases, which operates under long-term contracts with regulated-like returns. The proposed Essential Utilities acquisition would add regulated water and wastewater utilities in Ohio, North Carolina, and Texas while increasing its presence in Illinois, Indiana, Pennsylvania, New Jersey, and Virginia.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.